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Highlights: 7 
 Robotic liquid handling methods are developed for aqueous two-phase systems. 8 
 The importance of control of aspiration/dispense speeds and delay times is stressed. 9 
 The % bias accuracy of system preparation is assessed by gravimetric methods. 10 
 The critical effect of the geometry of the binodal on this accuracy is reported. 11 
 The methods are demonstrated as applied to the analysis of ovalbumin isoforms. 12 
Abstract: 13 
A robust strategy for the automated preparation of aqueous two-phase systems (ATPS) using 14 
a liquid handling sample processor was developed using gravimetric methods to determine the 15 
accuracy of preparation. The major robotic control parameters requiring adjustment were; 16 
speed of aspiration and dispense; delay times following aspiration and dispense alongside 17 
measures to control cross-contamination during phase sampling. In general mixture 18 
compositions of both polymer / polymer and polymer / salt mixtures could be prepared with a 19 
target bias accuracy of less than 5%. However we found that the bias accuracy with which 20 
systems of defined TLL and MR could be constructed was highly dependent on the tie line 21 
length of the ATPS and the geometrical form of the ATPS co-existence curve. For systems 22 
with a very low degree of curvature (PEG / salt systems here) increases in bias (accuracy) are 23 
appreciable at relatively long tie line lengths. Where the degree of curvature is more 24 
pronounced (PEG/dextran systems) closer approach to the critical point was possible without 25 
major effect on bias/accuracy. Application of the strategy to the measurement of the 26 
partitioning of phosphorylated and dephosphorylated forms of the model protein ovalbumin 27 
are reported. Differences in partition of phosphorylated (native) forms and dephosphorylated 28 
forms could be demonstrated. In a PEG/salt system this was manifest as a substantial decrease 29 
in solubility based on overall protein recovery derived from accurate knowledge of the system 30 
mass ratio. In a PEG/dextran system differences in partition coefficient could be demonstrated 31 
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1. Introduction: 36 
Partitioning in aqueous two phase systems (ATPS) has been widely used as an extraction and 37 
purification method for the recovery of biological macromolecules and particles as well as an 38 
analytical method for the study of proteins and other biomolecules. Aqueous two-phase systems 39 
(ATPS) form when two polymers or one polymer and a salt are mixed in appropriate amounts 40 
resulting in the formation of two immiscible phases. Since both phases are aqueous, biological 41 
functions are generally maintained [1].  Differential partition of added solutes may then be 42 
exploited preparatively and analytically. Some examples of recent preparative applications 43 
include: the continuous extraction of monoclonal antibodies using a multistage process [2], and 44 
the use of ATPS to improve the purification of Porcine Parvovirus Vaccine (PPV) in a PEG–45 
citrate system [3]. Examples of analytical applications include the measurement of biomolecule 46 
interactions [4], the analysis of protein isoforms [5] and the pre-concentration of virus to 47 
improve assay detection limits [6]. 48 
Since the partitioning method involves analyte distribution between completely liquid phases, 49 
the method may easily be adapted to conventional automated liquid handling techniques 50 
available in many laboratories. This approach has been taken in a number of studies, for 51 
instance in the screening of conditions for preparative process design employing ATPS [7,8] 52 
and for the automated preparation of analytical phase partitioning systems [9-12]. 53 
However, a few details have been reported of the practical development of automated methods 54 
for the preparation of ATPS, which involve the handling of relatively concentrated and viscous 55 
solutions of polymers and salts, nor is there much detail on the accuracy and reproducibility of 56 
their delivery. Accurate and reproducible phase system construction and subsequent sampling 57 
is a sine qua non for both analytical applications and screening for process development. 58 
We aimed in this work to develop a robust strategy for the preparation and sampling of aqueous 59 
two phase systems to minimize the % Bias (accuracy) and maximize the reproducibility of 60 
sample preparation. In so doing we found that the accuracy with which the final system 61 
composition could be prepared was dependent on the form of the co-existence curve of the 62 




2. Materials and methods: 64 
2.1. Materials 65 
Polyethylene glycol Mw=1000 (PEG1000) (Lot A0319044), Polyethylene glycol (Lot 66 
1356267) Mw=8000 (PEG8000) (Lot SLBC9317V), Ammonium sulfate (NH4)2SO4, di-67 
potassium hydrogen orthophosphate K2HPO4, potassium di-hydrogen orthophosphate KH2PO4, 68 
Tris (hydroxymethyl)-aminomethane (Tris) were purchased from Fisher Scientific UK 69 
(Leicester, UK). Dextran500 from Leuconostoc mesenteroides (Lot BCBJ7122V) weight-70 
average molecular weight (Mw) 450,000-650,000 and Ovalbumin from lyophilized powder, 71 
>98% (Lot SLBD2312V), Endoglycosidase F1 from Elizabethkingia miricola; recombinant, 72 
expressed in E.coli, ≥16U/mg buffered aqueous solution (Lot SLBK8022V), Neuraminidase 73 
from Clostridium perfringens (C. welchii) type V from lyophilized powder 0.32 mg solid 74 
7.9U/mg (N2876-2.5UN Lot SLBF5907V), Alkaline phosphatase (ALP) from bovine intestinal 75 
mucosa-BioUltra, in buffered aqueous glycerol solution 2000-4000 DEA U/mg protein (Lot 76 
SLBF3716V) and Cibacron Blue 3G-A (product No.C9534-25G) were purchased from Sigma-77 
Aldrich UK (Dorset, UK). 78 
2.2. Apparatus 79 
A Perkin Elmer MultiProbe II plus Liquid Handling Sample Processor (LHSP), fitted with a 4 80 
tip pipetting arm, controlled by WinPREP® applications software (PerkinElmer Life and 81 
Analytical Sciences, CT, USA) was used to prepare the ATPS. Either a Sartorius Mechatronics 82 
analytical balance 1601A MP8-1 (Epsom, UK) or a Denver instruments M-220D balance (NY, 83 
USA) both having a readability of 0.1mg were used for the gravimetric measurements. 84 
Analytical HPLC was performed using an Waters Alliance 2695 HPLC system with 2996 PDA 85 
Detector (Waters Corporation, Milford USA). Size Exclusion Chromatography was performed 86 
using a Shimadzu Isocratic HPLC system consisting of SCL-10A VP system controller, SPD-87 
10A Liquid chromatography pump and LC-10AT UV-VIS detector with data collection by 88 
Shimadzu EZStart chromatography software version 7.3 (Shimadzu Corporation, Analytical 89 
Instrument Division, Kyoto, Japan). 90 
2.3. Preparation of ATPS Stock Solutions 91 
PEG1000 and (NH4)2SO4 stock solutions were prepared by weight to final compositions of 40 92 




solutions of PEG8000 and Dextran500 were prepared by weight with compositions of 25 % 94 
w/w Dextran and 20 % w/w of PEG in 50 mM potassium phosphate buffer pH 7.4. 95 
Enzymatic dephosphorylation was performed by incubating ovalbumin with ALP [Addition of 96 
400 μL of 0.7 units/ μL ALP to 5 mL of protein at a concentration of 10 mg/mL] in 50 mM Tris 97 
buffer (pH 9) at 23°C overnight. 98 
Neuraminidase treatment: 20mg of ovalbumin was dissolved in 10 mL of 10mM phosphate 99 
buffer pH 6 to which 100µL Neuraminidase stock solution was added and the mixture was 100 
incubated at room temperature. Then samples were taken approximately every hour and 101 
analysed by Ion Exchange Chromatography (IEX). Neuraminidase stock solution was made up 102 
as follows: 0.32 mg neuraminidase in 1 ml 100 mM sodium acetate buffer pH 6, with 20 mM 103 
CaCl2.  104 
Enzymatic deglycosylation was attempted by incubating 2 μL Endo F1 with 37.5 μL ovalbumin 105 
at a concentration of 5.3 mg/mL in 10 μL of reaction buffer (provided with the enzyme kit 106 
(Endoglycosidase F1 from Elizabethkingia miricola)) at 37 °C overnight.  107 
2.4. Construction of the ATPS phase diagrams 108 
For the systems PEG8000-Dextran500 and PEG1000- (NH4)2SO4 phase diagrams were 109 
constructed by turbidimetric titration [13]. Tie lines connecting coexisting equilibrium phases 110 
were constructed for selected phase systems within the biphasic region following the method 111 
of Merchuk et al. [14]. The slope of the tie line (STL) was determined as the ratio STL = 112 
(ΔPEG)/ (ΔDextran) where Δ represents the difference in the concentration of each polymer in 113 
the two coexisting phases. 114 
2.5. Preparation of phase systems using the robotic system 115 
The LHSP was used to prepare ATPS having final masses of 3.5 g for PEG1000-(NH4)2SO4 116 
ATPS and 2 g for PEG8000-Dextran 500 ATPS. Stock solutions of polymers and salt were 117 
dispensed from the LHSP by volume and weighed on an analytical balance at each stage to 118 
provide calibration and performance data. Final compositions were achieved by addition of 119 
appropriate amounts of buffer or buffer containing analyte (Ovalbumin) and weighed as before.  120 
The stock solutions used to prepare the aqueous two-phase system selected for analysis of native 121 
ovalbumin in Tris (10 mM, pH 9) and ovalbumin treated with alkaline phosphatase in the same 122 
buffer after incubation for 24h at room temperature contained 25 % w/w  PEG-3350, 30 % w/w  123 




solutions for the preparation of a PEG1000-(NH4)2SO4 system were 40 %w/w PEG1000, 40 125 
%w/w (NH4)2SO4 and 150 mM potassium phosphate buffer pH 8.5. 126 
Partitioning experiments were performed using a set of eight different and increasing 127 
concentrations of protein added to a series of ATPS having the same overall polymer 128 
composition using a method outlined by Zaslavsky [15]. Systems were dispensed into test tubes 129 
and vortexed using a digital mini vortexer (3300rpm/sec, USA) for 10 sec, and centrifuged for 130 
20 min at 5000 rpm (Jouan DBV, France) to accelerate settling of the phases. After 131 
centrifugation, the tubes were returned to the deck of the LHSP. The LHSP was then used to 132 
prepare samples of 200 µL which were diluted with 800 µL of potassium phosphate buffer. 133 
Spectrophotometric absorbance at 280 nm (A280) was used to calculate protein concentration 134 
using an Extinction coefficient for ovalbumin of 30,590 cm-1 M-1 and a Molar Mass of 42.7 135 
kDa [16] and the partition coefficient was determined as the ratio of the sample concentration 136 
in the PEG-rich (top) phase to the sample concentration in the dextran-rich or salt-rich bottom 137 
phase.  138 
2.6. HPLC Analysis 139 
Strong anion exchange HPLC was used to separate ovalbumin isoforms on the basis of 140 
accessible surface charges and their corresponding electrostatic interaction with the column’s 141 
stationary phase. A SOURCE 15Q 4.6/100 PE column, GE Healthcare Life sciences, was used 142 
with; Mobile Phase A: 20 mM Potassium phosphate buffer, B: 20 mM phosphate buffer 143 
containing 500 mM Sodium chloride. A flow rate of 0.5 mL/min was used with a 100 uL 144 
injection volume. Samples were eluted using a linear gradient from 0 to 100 % buffer B over 145 
35 min. 146 
Protein samples were analysed by Size Exclusion Chromatography (SEC) using a TSKgel 147 
G2000 SW column; (5µm, 7.8 x 300 mm; Tosoh Bioscience purchased from HiChrom, 148 
Reading, UK). 0.05 M potassium phosphate buffer pH 7.0 containing 0.3 M NaCl was used to 149 
equilibrate the column at a flow rate of 0.4 mL/min with UV detection at 280 & 260 nm.   150 
 The SEC column was calibrated from the retention times of a Bio-Rad Gel Filtration Standard 151 
(Catalog 151-1901) having molecular weight markers ranging from 1,350 to 670,000 Da. 152 
3. Results and discussion: 153 




The performance of all liquid-handling steps of the LHSP are controlled by an instrumental 155 
performance file which can be used to adjust a wide range of parameters as the speed and the 156 
delay time of dispensing and aspirating as well as the height of the probe tips. We found that 157 
the most important parameters were control of (decrease from the instrument default settings) 158 
the speed of delivery during both aspiration and dispense and the time delay following both 159 
aspiration and dispense. Aspiration rate for the PEG1000 stock solution (40 %w/w) for volumes 160 
in the range 100 - 2000 µL was set at 5 µL/s, and for the PEG8000 stock solutions (20 %w/w) 161 
in the range 100 - 2000 µL was set at 10 µL/s.  For the Dextran stock solution (25 % w/w) for 162 
volumes of >100, >250, >400, and 900-2000 µL) the aspiration speed was set at 5, 10, 12.5 and 163 
15 µL/s respectively. Finally, for stock salt solutions (40 %w/w) for volumes of >100, and 250 164 
- 2000 µL the aspiration speed was set at 6 and 10 µL/s respectively. The speed of dispense was 165 
also reduced, for PEG 1000 the speed of dispense was 15 µL/s over the same volume range as 166 
above, whilst for salt the dispense speed was set at 100 µL/s. 167 
For PEG8000 the dispense speed over the volume range >100, and 250-2000 µL was set at 400 168 
and 300 µL/s while for Dextran500 this was set at 100 and 30 µL/s over the same range of 169 
volumes. 170 
The height of the probe tips was also adjusted; during aspiration this was set so that the tips 171 
entered 2 mm below the liquid surface to avoid air entry and during dispense the tips were 172 
positioned either 1 mm below the liquid surface or 5 % above the tube bottom so that any drops 173 
remaining on the tips after dispense were removed by contact with the liquid surface. 174 
Finally, the time delays between the end of aspiration and dispense and tip withdrawal was 175 
extended to ensure that the procedure was complete. The aspiration delay for PEG1000, 176 
PEG8000 and salt stock solutions for volumes in the range 100 - 400 µL was set at 200 ms. 177 
Whilst for volumes of 400-2000 µL this was set at 300 ms.  For Dextran500 stock solutions this 178 
was further extended to 800 ms. We also found it necessary to adjust LHSP performance 179 
parameters and to calibrate the sampling procedure for phase sampling in the same way as 180 
previously described for system preparation. 181 
Conservatively we used the PEG8000 performance parameters for sampling top phases and the 182 
Dextran500 performance parameters for sampling bottom phases with both PEG-Dextran and 183 
PEG-salt systems. 184 
We found that cross-contamination of the phases was problematic during phase sampling since 185 




visualised during exploratory experiments by including a dye (Cibacron Blue 3G-A) in the 187 
ATPS which strongly partitioned to the upper PEG phase and was readily visible in lower phase 188 
when cross-contamination occurred. This was overcome by creating the following three-step 189 
sampling procedure; 1.  Sample 400µL of each top and bottom phase, 2. Centrifuge these 190 
samples to separate any residual contaminating phase, 3. Re-sample 200µL from each separated 191 
phase. 192 
The following gravimetric procedure was used to pre-calibrate the LHSP for the delivery of 193 
ATPS components. For each stock solution the relationship between demanded volume and 194 
delivered mass was measured gravimetrically. Delivery of a range of volumes between 50 µL 195 
and 1.4 mL was examined for each stock solution without any volume compensation. Thus at 196 
this stage a linear relationship between delivered mass and demanded volume was assumed 197 
having a slope of 1 and offset value of 0 as defined in Eq. (1). 198 
𝑊 = 𝑉. 𝑥 +  𝐶      (1) 199 
Where W is the mass delivered, V is volume demanded, x is the slope and C is the intercept 200 
value. The true relationship between the volume demanded and the weight delivered was 201 
determined from gravimetric determinations of the delivered mass and a new slope and offset 202 
calculated. These values were then used to set the volume compensation of the LHSP. Note that 203 
this is equivalent to a determination of the density of the stock solutions and that a similar 204 
procedure could be implemented through performance files in the absence of a volume 205 
compensation parameter. This procedure which was repeated for the delivery of all stock 206 
solutions required to form the ATPS may be summarized as; 1. Dispense the first component 207 
without volume compensation, 2. Gravimetrically determine the delivered mass, 3. Calibrate 208 
the LHSP with this delivered vs demanded relationship, 4. Confirm the accuracy of the 209 
calibration, 5. Repeat for each additional component. 210 
Once the above pre-calibration procedure had been completed for all components of the ATPS 211 
the performance of the LHSP in delivering a specific ATPS composition of defined Tie Line 212 
Length (TLL) was examined. 213 
To give a specific example, 8 replicates of a PEG1000-(NH4)2SO4 system (TLL: 38.9 % w/w 214 
composed of 16.18 % w/w PEG1000 and 17.48 % w/w (NH4)2SO4) and a PEG8000-215 
Dextran500 system (TLL: 24.1 % w/w composed of 5.67 % w/w PEG8000 and 10.84 % w/w 216 
Dextran500) were constructed using the volume compensations previously established for each 217 




was dispensed in turn and the results examined gravimetrically. The whole procedure was 219 
replicated three times. The results are shown in Fig. 1 and 2.  220 
Insert Figure 1 221 
Insert Figure 2 222 
Although the composition of each of the components of each system was within 1 % of the 223 
target composition there was systematic deviation from the target. For the PEG -salt system, 224 
the PEG concentration was lower than required and vice versa for the salt, while for the PEG-225 
Dextran system the PEG concentration was higher than required and the Dextran concentration 226 
varied above and below the target. Several reasons may be adduced for this; first the regression 227 
is the best fit through the calibration data and may not perfectly describe all individual 228 
compositions within the range. Secondly, the final fractional composition of the system is a 229 
function of each added component, since: 230 
Tm = Xm + Ym + Zm     231 
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   (4) 236 
Where Tm is the total system mass, 𝑋𝑚, 𝑌𝑚, 𝑍𝑚 are the mass of the three major components of 237 
the ATPS (salt or dextran, PEG, and buffer respectively) and XF, YF are the mass fractions of 238 
each component.  239 
From these results the %Bias (accuracy) in the delivery was determined for each component.  240 
% Bias was determined from the actual mass dispensed relative to the intended mass as shown 241 
in the Eq. (5). Where MA is actual mass dispensed and MO is the intended mass [17]. 242 
%Bias (accuracy)  = (
(MA−M0)
M0
) ∗ 100      (5) 243 
In an attempt to correct these systematic deviations we elected to use the mean % Bias converted 244 
to a volume basis as a correction factor applied to the demanded volume of PEG and salt or 245 





As a result of applying this correction, the mean composition of the systems was brought much 248 
closer to the target value; however the range was not generally improved as shown in Fig.3 (see 249 
also Table S1 in the Supplementary material). 250 
Insert Figure 3 251 
Subsequently we constructed a PEG-salt system (8 replicates as before) at a reduced TLL (25.57 252 
% w/w compared to the previous TLL of 38.9 % w/w). We found that the % Bias in the 253 
compositions of the PEG and salt was comparable at each TLL as shown in Table 1. 254 
Insert Table 1 255 
For each of the eight systems constructed at each nominal TLL, the actual TLL of the delivered 256 
systems was calculated from their gravimetric compositions.  Under the assumption that the 257 
slope of each tie line (STL) is the same for all tie lines lying very close together, the TLL for 258 
each constructed system was calculated by numerical methods from its slope and intersection 259 
with the binodal curve. From this estimate of the TLL and the system composition the mass 260 
ratio (MR) of the each of the eight systems could be obtained along with the % Bias of both 261 
TLL and MR.  262 
The mean % Bias of the mass ratio (MR) and TLL was found to be greater at shorter TLL. This 263 
must affect the variability (error in determination) of the partition coefficient (K) of added 264 
solutes at shorter TLL since K is a function of TLL [1]. In addition the increase in % Bias 265 
(accuracy) of MR of systems lying closer to the critical point will similarly compromise the 266 
calculation of the mass balance of the ATPS. This is an important consideration when systems 267 
approach the analyte solubility limit or where molecular association occurs. 268 
On the basis of this finding we used the range in system compositions already found to be 269 
delivered by LHSP to estimate the %Bias of TLL and MR for a series of tie lines chosen to lie 270 
increasingly close to the critical point for each PEG-salt and PEG-Dextran ATPS (see Tables 2 271 
& 3). For each TLL examined in both of these phase systems the compositions of four 272 
hypothetical systems were calculated. The composition of these systems was assigned such that 273 
they lay two standard deviations (SD) (based on the distribution of the data already found for 274 
the PEG/salt system (TLL 38.9 % w/w) and the PEG Dextran system (TLL 24.1 % w/w)) above 275 
and below the phase compositions of a system having mass ratio of 1 at each TLL, thus 276 
encompassing 95% of the previously determined experimental variability. The compositions of 277 
these hypothetical systems may be expressed as X+2SD Salt, Y+2SD PEG; X-2SD Salt, Y-278 




Dextran system.  Note that these systems form a rectangle surrounding the selected target 280 
composition with one pair (X-2SD Salt or Dextran, Y+2SD PEG and X+2SD Salt or Dextran, 281 
Y-2SD PEG) lying approximately parallel to the slope of the TLs and the opposite pair lying 282 
approximately orthogonal to this slope. 283 
Insert Table 2 284 
Insert Table 3 285 
The effect of the variability in system range (SR) composition on the % bias in TLL and MR 286 
for the PEG8000-Dextran500 system is shown in Fig. 4 A&B. The % Bias (accuracy) of TLL 287 
length is within ±1% of the target value at long TLL and even at the shortest TLL examined 288 
only increases to about ± 2%. Similar results were found for the effect of variability in system 289 
composition on the % Bias (accuracy) of MR in this system. These results seem quite acceptable 290 
in the context of automated system preparation; erroneous results due to excessive variability 291 
of TLL and its effect on the partition coefficient or due to large changes in MR and its effect 292 
on mass balance calculations are unlikely at any but the very shortest tie line lengths say below 293 
13 % w/w. 294 
Insert Figure 4 295 
It seems to be accepted that for automated sample preparation in analytical applications % Bias 296 
should be within 5%, although this criterion appears to be more relaxed for very high throughput 297 
minimal volume systems such as may be used in pharmaceutical lead analysis [18].  298 
Similar results showing the effect on % Bias (accuracy) of TLL in the preparation of the PEG-299 
1000 Ammonium sulphate system using parameters derived from the LHSP performance data 300 
for the target range of TLLs given in Table 3 are shown in Fig. 5A. The % Bias in TLL of the 301 
shortest TLL examined (12.2 % w/w) for systems lying orthogonal to the TLs were found to be 302 
very much greater than 5% (+42% and -100%). The latter because this TL composition lies 303 
outside the co-existence curve and would fail to form a biphasic system. Similar results were 304 
found for MR (see Figure 5B), at the shortest TLL, % Bias in MR is in excess of 10% and the 305 
% Bias of one system reported as 0% is meaningless as it again lies outside the binodal curve. 306 
Increase in TLL to 25 % w/w results in a reduction in % Bias (accuracy) of both TLL and MR; 307 
however % Bias (accuracy) of TLL is close to ±10% and greater than 5% for MR. 308 




Note that system pairs lying approximately parallel to the target tie line lead to the greatest error 310 
in MR and for those lying orthogonal to the Tie line to the greatest error in TLL.  By 32 % w/w 311 
TLL the error associated with TLL and MR is only marginally acceptable being still somewhat 312 
greater than 5% at 2SD from the mean. At longer tie line lengths % bias accuracy is reduced to 313 
more acceptable levels. 314 
In conclusion, in systems where % Bias (accuracy) is much greater than 10 %, partitioning 315 
measurements could only be accurately made with complete knowledge of system composition 316 
obtained gravimetrically or photometrically [8] or perhaps by the exhaustive determination of 317 
numerous replicates. 318 
The % Bias accuracy of TLL and MR increases more rapidly in PEG-salt systems than in 319 
PEG/Dextran systems as tie line length is reduced. The reasons behind this difference are 320 
related to differences in the form of the co-existence curve for these systems. In the PEG-salt 321 
system the curvature of the co-existence curve is very low and the TLs run almost parallel to 322 
the co-existence curve with the result that the TLL increases rapidly with distance from the 323 
critical point. Figure 6 shows the phase diagrams for the systems used here along with the 324 
instantaneous radius of curvature of the binodal curve which may be calculated from the 325 
curvature defined as:  326 





      [6], 327 
where y represents a function, which describes the binodal curve [19]. It is immediately 328 
apparent that the curvature of the PEG-salt system is very low and the radius is consequently 329 
very high in comparison to the PEG-dextran system. This is likely to be true for many, but 330 
perhaps not all, relatively high Mw. PEG-salt systems. In some PEG-salt systems in the region 331 
of the critical point the curvature of the co-existence curve approaches zero i.e. is almost a 332 
straight line see for instance the many phase diagrams given in [20]. 333 
Insert Figure 6 334 
On the other hand in the PEG8000-Dextran500 system examined here, this effect is much less 335 
pronounced and the co-existence curve has by comparison considerable curvature; this is likely 336 
to be the case for many, but not all, polymer-polymer systems. As a consequence the relative 337 
increase in TLL (equivalent to the chord length) is more modest as the distance from the critical 338 
point increases and the impact of error in system preparation is consequently much reduced. In 339 




curvature and disposition of the tie lines of the system is important for their accurate preparation 341 
particularly when attempting to work close to the critical point. 342 
3.2. Analytical Example of the Application of the Automated Procedure 343 
The automated phase system preparation and sampling procedure was applied to the analytical 344 
determination of the isoforms of a model protein, ovalbumin, since in the native state it consists 345 
of several isoforms having differences in glycosylation [21] and phosphorylation [22]. 346 
If the effect of these post translational modifications (PTMs) on the partition coefficient of the 347 
model protein could be quantified it would be possible to develop the partitioning technique as 348 
a simple method to detect and quantify particular PTMs, for example in the detection of clinical 349 
biomarkers or as quality control attributes during industrial bioprocessing. 350 
To this end we elected to compare the partitioning of native ovalbumin to dephosphorylated 351 
and deglycosylated forms of the protein prepared enzymatically in vitro. Neuraminidase was 352 
used in an attempt to prepare ovalbumin depleted in nueraminic acid residues [21] and the 353 
endoglycosidase Endo F was used to prepare substantially deglycosylated forms [23]. 354 
Unfortunately neither of these methods was successful in creating isoforms substantially 355 
different from the native form when analysed by IEX (data not shown) despite the fact that 356 
other workers have had at least partial success in generating substantially deglyosylated forms 357 
[21]. 358 
On the other hand alkaline phosphatase was successfully used to prepare a substantially 359 
dephosphorylated form of native ovalbumin (see materials and methods). Analytical IEX was 360 
used to demonstrate that ovalbumin was substantially dephosphorylated post ALP treatment 361 
(see Supplementary materials Fig. S1 and S2). SEC was used to show that the resulting de-362 
phosphorylated ovalbumin was in other respects identical to the native form in terms of the 363 
amount of multimeric and aggregated species present. Size Exclusion Chromatography (SEC) 364 
was used to assess the effect of dephosphorylation on the molecular integrity and degree of 365 
aggregation of ovalbumin. Removal of phosphate groups was found to produce a change in the 366 
normalised retention time of the phosphorylated and de-phosphorylated species. This could be 367 
interpreted as a change in molecular size with ALP-treated ovalbumin having an apparent molar 368 
mass of 40.9 kDa compared to 43.6 kDa of the native state as illustrated in the separation of 369 
Bio-Rad standard in Fig. S3 and the effect of dephosphorylation in Fig. S4 in Supplementary 370 




degradation or extent of aggregation or the presence of multimeric species (See Supplementary 372 
materials Fig. S4 and Table S2).  373 
Phosphorylation affects the surface charge and charge density of the proteins and may induce 374 
conformational change and changes in hydrophobicity which should be reflected in changed 375 
interaction parameters with the ATPS components and hence in the partition coefficient. 376 
The partitioning behaviour in ATPS of ALP treated and native untreated ovalbumin was 377 
examined in order to determine the influence of dephosphorylation on the partition coefficient 378 
using the previously established experimental design. 379 
Initially, a number of systems were screened for their ability to discriminate between ALP 380 
treated and native ovalbumin. These systems were: PEG600-Na2SO4, PEG600-(NH4)2SO4, 381 
PEG1000-(NH4)2SO4, PEG8000-Dextran500, PEG4600-Dextran500 and PEG3350-382 
Dextran500. Each of the PEG-salt systems was found to have its own shortcomings for instance: 383 
in the PEG600-Na2SO4 system the maximum solubility of the salt was found to be 14 % w/w 384 
which in preparing systems from stock solutions left little room for sample addition. Also the 385 
Low molecular weight PEG600-(NH4)2SO4 system amplified the partition coefficient (K=8.5) 386 
precluded accurate determination of lower phase concentration by A280. In the PEG1000-387 
(NH4)2SO4 system dephosphorylated ovalbumin was found to have greatly reduced solubility 388 
compared to the native form which led to accumulation at the interface and a failure to close 389 
the mass balance (Fig. 7 A&B) compared to the PEG3350-Dextran500 system (Fig. 8 A&B ). 390 
Insert Figure 7 391 
Insert Figure 8 392 
Little difference in partitioning behaviour was found for the PEG-Dextran systems mentioned 393 
above except in the PEG3350-Dextran500 system. For each of the aforementioned PEG-394 
Dextran systems, A range of systems were screened containing 10mM phosphate buffer but 395 
differing in pH (4.6, 5.5, 7.4, and 9) and with respect to different added salts (100mM NaClO4, 396 
100mM KCl, 50mM K2SO4) (data not shown). Over this limited survey the best result (greatest 397 
difference in K between ALP treated and native (untreated) ovalbumin was found in a 398 
PEG3350-Dextran500 system containing 10mM phosphate buffer pH 9 containing 50mM 399 
potassium sulfate salt. This result is shown in Fig. 8 A&B. The slope of the relationship between 400 
the concentration in the top and bottom phase corresponds to the partition coefficient [15] and 401 
this was shown to be significantly different by analysis of covariance (Table S3 in 402 





Since ATPS are composed of entirely liquid phases they lend themselves to the application of 405 
automated liquid handling techniques for their preparation and thus to applications in extensive 406 
screening programmes for example to rapidly screen systems for optimal recovery conditions 407 
in bioprocessing or to detect the occurrence of process variants or isoforms during bioprocess 408 
development or in clinical analysis. In attempting to develop a robust liquid handling strategy 409 
for these viscous liquid systems which minimised bias and maximised reproducibility we found 410 
the following control parameters of particular importance. It was necessary to considerably 411 
reduce speeds of aspiration and dispense compared to those conventionally used and 412 
recommended as standard. In addition delay times of aspiration and dispense had also to be 413 
extended. It was also necessary to ensure that dispensed droplets were fully disengaged from 414 
the liquid handling probes and that steps were taken to eliminate carry over and cross 415 
contamination of phases during sampling. Such adjustments to the operation of LHSP devices 416 
should be widely applicable and maybe implemented on most liquid handling systems. With 417 
these precautions in place it was possible to construct polymer / polymer and polymer / salt 418 
mixtures whose bias accuracy of final composition fell well within target values of 5%. 419 
However we also found that for the accurate preparation of ATPS close to the critical point the 420 
geometrical form of the phase diagram co-existence curve was of crucial importance since this 421 
directly affected the accuracy with which systems of defined TLL and MR could be constructed. 422 
For systems with a very low degree of curvature, PEG / salt systems in this example, increases 423 
in bias (accuracy) are appreciable at relatively long tie line lengths. Where the degree of 424 
curvature is more pronounced, PEG/dextran systems here, closer approach to the critical point 425 
is possible without major effect on bias/accuracy. These findings are not dependent on the liquid 426 
handling system used but are a consequence of the nature of the ATPS phase diagram. Using 427 
the robotic methods that were developed we examined the partition of the model protein 428 
ovalbumin. A strategy involving dephosphorylation and deglycosylation was used to prepare 429 
substantially different isoforms. Deglycosylation proved unsuccessful but differences in 430 
partition of phosphorylated (native) forms and dephosphorylated forms could be demonstrated. 431 
In a PEG/salt system we examined this was manifest as a substantial decrease in solubility 432 
based on overall protein recovery derived from accurate knowledge of the system mass ratio. 433 
In a PEG/dextran system we examined differences in partition coefficient could be 434 





The first author especially would like to thank Iraqi Ministry of High Education & Scientific 437 
Research and University of Karbala for funding this project as part of her PhD (Ref. No. 643 438 
from 10/01/2013). Furthermore, the authors are grateful to Prof Derek Fisher for support and 439 




[1] P. A. Albertson, Partition of cell particles and macromolecules, second ed., Wiley-444 
Interscience, New York, 1971. 445 
[2] J. Mündges, J. Zierow, T. Zeiner, Experiment and simulation of an aqueous two-phase 446 
extraction process for the purification of a monoclonal antibody, Chem. Eng. Process, 447 
95 (2015) 31-42. 448 
[3] K.S. Vijayaragavan, A. Zahid, J.W. Young, C.L. Heldt, Separation of porcine 449 
parvovirus from bovine serum albumin using PEG-salt aqueous two-phase system, J. 450 
Chromatogr. B, 967 (2014) 118-126. 451 
[4] P.A. Albertsson, Interaction between biomolecules studied by phase partition, in: D. 452 
Glick (Ed.), Methods of Biochemical Analysis, Wiley, New York, 1983, pp. 1-24.  453 
[5] A. Zaslavsky, N. Gulyaeva, A. Chait, B. Zaslavsky, A new method for analysis of 454 
components in a mixture without preseparation: evaluation of the concentration ratio 455 
and protein±protein interaction, Anal. Biochem. 296 (2001) 262–269.  456 
[6] E. Jue, C.D. Yamanishi, R.Y.T. Chiu, B.M. Wu, D.T. Kamei, Using an aqueous two-457 
phase polymer-salt system to rapidly concentrate viruses for improving the detection 458 
limit of the lateral-flow immunoassay, Biotechnol Bioeng, 111 (2014) 2499-2507. 459 
[7] M. Bensch, B. Selbach, J. Hubbuch, High throughput screening techniques in 460 
downstream processing: preparation, characterization and optimization of aqueous two-461 
phase systems, Chem. Eng. Sci., 62 (2007) 2011-2021. 462 
[8] M. Wiendahl, C. Volker, I. Husemann, J. Krarup, A. Staby, S. Scholl, J. Hubbuch, A 463 
novel method to evaluate protein solubility using a high throughput screening approach, 464 
Chem. Eng. Sci., 64 (2009) 3778-378. 465 
[9] A. Chait, B.Y. Zaslavsky, , (2011) U.S. Patent No.7,968,350B2.  466 
[10] A. Chait, B.Y. Zaslavsky, (2012) U.S. Patent No. 8,211,714 B2.  467 




[12] A. Zaslavsky, P. Madeira, L. Breydo, V. N. Uversky, A. Chait, B. Zaslavsky, High 469 
throughput characterization of structural differences between closely related proteins in 470 
solution, Biochim. Biophys. Acta., 1834 (2013) 583–592. 471 
[13] A. Kaul, The phase diagram, in: H.R. Kaul (Ed.), Methods in Biotechnology, Aqueous 472 
Two-Phase Systems: Methods and Protocols, Humana Press, New Jersey, 2000, pp. 11-473 
22. 474 
[14] J.C. Merchuk, B.A. Andrews, J.A. Asenjo, Aqueous two-phase systems for protein 475 
separation studies on phase inversion, J. Chromatogr. B, 711 (1998) 285–293.  476 
[15]  B.Y. Zaslavasky, Aqueous two-phase partitioning: Physical chemistry and 477 
bioanalytical applications, Marcel Dekker Inc., New York, 1995, pp 223-232. 478 
[16] Worthington Enzyme Manual. Worthington, K., and Worthington, V. (2011). 479 
Worthington Biochemical Corporation. date of access 29/01/2016 480 
(http://www.worthington-biochem.com/OA/default.html). 481 
[17]  C. Croarkin, NIST SEMATECH e-Handbook of Statistical Methods, 482 
http://www.itl.nist.gov/div898/handbook/, Last updated: 10/30/2013. 483 
[18] C.C. Sergio, A.N. Goktug, J. Cui, J. Low and T. Chen,  Practical Considerations of 484 
Liquid Handling Devices, in: H.A. El-Shemy (Ed.), Drug Discovery, In Tech, Rijeka, 485 
Croatia, 2013, pp. 177-200. 486 
[19] M. Kline, Calculus: An Intuitive and Physical Approach, Dover 1998, pp. 457-461 487 
[20] J.G. Huddleston , H.D. Willauer and R.D. Rogers, Phase diagram data for several PEG 488 
+ salt aqueous biphasic systems at 25 °C, J. Chem. Eng. Data, 48 (2003) 1230–1236.  489 
[21] Y. Yang, A. Barendregt, J.P. Kamerling and A.J.R. Heck., Analyzing protein micro-490 
heterogeneity in chicken ovalbumin by high-resolution native mass spectrometry 491 
exposes qualitatively and semi-quantitatively 59 proteoforms, Anal. Chem., 85 (2013) 492 
12037-12045. 493 
[22] J.Y. Henderson, A.J. Moir, L.A. Fothergill, J.E. Fothergill, Sequences of sixteen 494 
phosphoserine peptides from ovalbumin of eight species, Eur. J. Biochem., 114 (1981) 495 
439-50. 496 
[23] H.J. Elder and S. Alexander, Endoβ-N-Acetylglucosaminidase F: Endoglycosidase from 497 
'Flavobacterium meningosepticum -that cleaves both high-mannose and complex 498 
glycoproteins, Proc. Natl. Acad. Sci., 79 (1982) 4540-4544. 499 




List of Figures: 501 
Figure 1.  Box Plots of the Phase compositions of PEG1000 – (NH4)2SO4  system in terms of  502 
(A) % w/w PEG1000 and (B) % w/w (NH4)2SO4, following a pre-calibration procedure (No. 503 
1-3) and a post calibration adjustment (No. 4-6). The black Line within the box represents the 504 
mean of data; the red line represents the median. 505 
Figure 2.  Box Plots of the Phase compositions of PEG8000 – Dextran500 system in terms of  506 
(A) % w/w PEG8000 and (B) % w/w Dextran500, following a pre-calibration procedure (No. 507 
1-3) and a post calibration adjustment (No. 4-6). 508 
Figure 3.  (A) PEG1000-(NH4)2SO4, (B) PEG8000 –Dextran500 systems show the accuracy 509 
of the delivery of the final system composition following pre and post calibration procedures, 510 
() Demand system, () Pre-Calibration systems, () Post-Calibration systems. 511 
Figure 4. Modelled variability in the composition of a PEG8000-Dextran500 system in terms 512 
of (A) the %Bias (accuracy) of the TLL and (B) the %Bias (accuracy) of the MR. Each 513 
symbol represents the modelled system range of known TLL () TLL1   ()TLL2  ()TLL3  514 
()TLL4     ()TLL5 ,  illustrating the effect of TLL on the % Bias accuracy in TLL and MR 515 
in the construction of ATPS. . (PEG 8000-Dextran500 system TLL were listed in Table 3)  516 
Figure 5.  Modelled variability in the composition of a PEG1000- (NH4)2SO4 system in terms 517 
of the (A) %Bias (accuracy) of the TLL and (B) %Bias (accuracy) of the MR. Each symbol 518 
represents the modelled system range of known TLL () TLL1 () TLL2 () TLL3 () 519 
TLL4 () TLL5 () TLL6 () TLL7, illustrating the effect of TLL on the % Bias accuracy 520 
in TLL and MR in the construction of ATPS. (PEG1000-(NH4)2SO4 system TLL were listed 521 
in Table 2). 522 
Figure 6.  Phase diagrams of (A) the PEG8000–Dextran500 system and (B) the PEG1000-523 
(NH4)2SO4 system showing the coexistence curves and disposition of the tie lines and 524 
illustrating the considerable difference in curvature of their co-existence curves. 525 
Figure 7.  Partition of (A) native and (B) ALP treated ovalbumin in the PEG1000- (NH4)2SO4 526 
system showing the concentration in the top (●) and bottom (■) phases and the overall 527 
recovery from both phases (▲). 528 
Figure 8.  Partition of (A) native and (B) ALP treated ovalbumin in the PEG3350-Dextran500 529 
system showing the concentration in the top (●) and bottom (■) phases and the overall 530 




List of Tables: 532 
Table 1. Mean % bias (accuracy) of system component composition, TLL and MR for two 533 
different TLLs of the PEG1000-(NH4)2SO4 system 534 
Table 2. Systems selected for analysis of the effect of variability in construction on the TLL 535 
and MR of the PEG1000 - (NH4)2SO4 ATPS 536 
Table 3. Systems selected for analysis of the effect of variability in construction on the TLL 537 
and MR of the PEG8000-Dextran500 ATPS 538 
 539 




Fig. 1A 541 
No. of Experiment 















Fig. 1B 543 
No. of Experiment 


















Figure 1.  Box Plots of the Phase compositions of PEG1000 – (NH4)2SO4  system in terms of  545 
(A) % w/w PEG1000 and (B) % w/w (NH4)2SO4, following a pre-calibration procedure (No. 546 
1-3) and a post calibration adjustment (No. 4-6). The black Line within the box represents the 547 
mean of data; the red line represents the median. 548 
 549 




Fig. 2A 551 
No. of experiment 
















Fig. 2B 553 
No. of experiment 
















Figure 2.  Box Plots of the Phase compositions of PEG8000 – Dextran500 system in terms of  555 
(A) % w/w PEG8000 and (B) % w/w Dextran500, following a pre-calibration procedure (No. 556 
1-3) and a post calibration adjustment (No. 4-6). 557 




Fig. 3A 559 
Ammonium sulphate % w/w














Fig. 3B 561 
 PEG 8000 % w/w


















Figure 3. (A) PEG1000-(NH4)2SO4, (B) PEG8000 –Dextran500 systems show the accuracy of 563 
the delivery of the final system composition following pre and post calibration procedures, () 564 
Demand system, () Pre-Calibration systems, () Post-Calibration systems. 565 




Fig. 4A 567 
Tie Line Length (TLL) % w/w














Fig. 4B 569 
Tie Line Length (TLL) % w/w




















Figure 4. Modelled variability in the composition of a PEG8000-Dextran500 system in terms 571 
of (A) the %Bias (accuracy) of the TLL and (B) the %Bias (accuracy) of the MR. Each 572 
symbol represents the modelled system range of known TLL () TLL1   ()TLL2  ()TLL3  573 
()TLL4     ()TLL5 ,  illustrating the effect of TLL on the % Bias accuracy in TLL and MR 574 
in the construction of ATPS. . (PEG 8000-Dextran500 system TLL were listed in Table 3)  575 




Fig. 5A 577 
Tie Line Length (TLL) % w/w


















Fig. 5B  579 
Tie Line Length (TLL) % w/w























Figure 5.  Modelled variability in the composition of a PEG1000- (NH4)2SO4 system in terms 581 
of the (A) %Bias (accuracy) of the TLL and (B) %Bias (accuracy) of the MR. Each symbol 582 
represents the modelled system range of known TLL () TLL1 () TLL2 () TLL3 () 583 
TLL4 () TLL5 () TLL6 () TLL7, illustrating the effect of TLL on the % Bias accuracy 584 
in TLL and MR in the construction of ATPS. (PEG1000-(NH4)2SO4 system TLL were listed 585 




Fig. 6A 587 
Dextran 500 / PEG 8000
PEG 8000 % w/w







































Fig. 6B 589 
PEG 1000 / Ammonium Sulphate
Ammonium Sulphate % w/w





































Figure 6.  Phase diagrams of (A) the PEG8000–Dextran500 system and (B) the PEG1000-591 
(NH4)2SO4 system showing the coexistence curves and disposition of the tie lines and 592 
illustrating the considerable difference in curvature of their co-existence curves. 593 




Fig. 7A 595 
Overall  [Ovalbumin] (mg/mL) in the ATPS





























































Fig. 7B 597 
Overall [Ovalbumin] (mg/mL) in the ATPS




























































Figure 7.  Partition of (A) native and (B) ALP treated ovalbumin in the PEG1000- (NH4)2SO4 599 
system showing the concentration in the top (●) and bottom (■) phases and the overall 600 
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Figure 8.  Partition of (A) native and (B) ALP treated ovalbumin in the PEG3350-Dextran500 607 
system showing the concentration in the top (●) and bottom (■) phases and the overall 608 
recovery from both phases (▲). 609 




Table 1. Mean % bias (accuracy) of system component composition, TLL and MR for two 611 







PEG (NH4)2SO4 PEG (NH4)2SO4 
Delivered, % w/w 16.16 17.50 16.41 14.76 
%Bias -0.12 0.07 -0.15 0.43 
Delivered system TLL 38.89 26.27 
Delivered system Mass Ratio 0.998 0.93 
TLL %Bias -0.05 2.75 
Mass Ratio %Bias -0.19 -7.08 
 614 
 615 
Table 2. Systems selected for analysis of the effect of variability in construction on the TLL 616 









TLL % w/w 
 
STL 
TL1 15.03 14.98 12.19 -1.482 
TL2 16.42 14.69 25.56 -1.467 
TL3 16.96 15.07 32.46 -1.44 
TL4 16.17 17.49 38.91 -1.236 
TL5 17.84 18.02 45.62 -1.24 
TL6 19.11 18.76 49.64 -1.176 
TL7 20.47 19.47 53.04 -1.077 
 619 




Table 3. Systems selected for analysis of the effect of variability in construction on the TLL 621 
and MR of the PEG8000-Dextran500 ATPS 622 
 623 
No. of Tie 
line 








TL1 7.097 3.74 13.08 -2.557 
TL2 9.08 4.49 19.50 -2.377 
TL3 10.85 5.67 24.10 -2.066 
TL4 12.84 5.93 28.11 -2.249 





Supplementary Materials. Table S1 [A]. Comparison of the mean % Bias of ATPS prepared following pre-calibration alone and prepared following 625 





Accuracy Coefficient of variation 
CV% Pre-Calibration 
Mean %Bias 
Accuracy Coefficient of variation 
CV% Post-Calibration 
%Bias Accuracy %Bias Accuracy Pre-Calibration Post-Calibration 
 PEG Salt PEG Salt PEG Salt PEG Salt PEG Salt PEG Salt 
1 -0.584 0.826 0.305 -0.074 
-0.953 0.665 0.002 0.002 -0.115 0.0677 0.003 0.003 
2 -0.886 0.932 -0.081 0.313 
3 -0.838 0.788 0.15 0.058 
4 -0.963 0.678 0.091 -0.156 
5 -1.024 0.62 -0.369 0.414 
6 -1.098 0.583 -0.325 0.245 
7 -0.99 0.423 -0.011 -0.401 
8 -1.239 0.469 -0.686 0.141 
1 -1.008 1.291 0.026 0.315 
-0.878 0.6 0.003 0.004 -0.097 -0.044 0.008 0.005 
2 -0.754 0.767 0.333 0.024 
3 -0.389 0.31 0.552 -0.475 
4 -0.956 0.671 -0.611 0.372 
5 -1.256 0.693 -0.646 0.538 
6 -0.832 0.603 -0.021 -0.307 
7 -0.813 0.23 0.369 -0.897 
8 -1.017 0.236 -0.783 0.079 
1 -0.429 1.342 0.043 -0.152 
-0.646 1.928 0.002 0.009 0.013 0.087 0.003 0.003 
2 -0.693 1.533 -0.001 0.179 
3 -0.989 3.524 -0.342 -0.068 
4 -0.795 1.072 0.212 0.213 
5 -0.772 1.256 0.281 0.167 
6 -0.488 1.728 0.307 0.403 
7 -0.626 2.915 -0.34 0.089 




Table S1 [B]. Comparison of the mean % Bias of ATPS prepared following pre-calibration alone and prepared following pre and post calibration of the 627 
PEG8000-Dextran500 system 628 
Set of 
runs 




Coefficient of variation 
CV% Post-Calibration 
%Bias Accuracy %Bias Accuracy Pre-Calibration Post-Calibration 
 PEG Dextran PEG Dextran PEG Dextran PEG Dextran PEG Dextran PEG Dextran 
1 0.751 0.648 -0.283 -0.090 
0.395 0.363 0.003 0.002 -0.035 0.044 0.004 0.004 
2 0.598 0.314 -0.054 -0.070 
3 0.427 0.175 0.769 -0.599 
4 0.523 0.443 0.162 -0.396 
5 -0.150 -0.038 -0.132 0.449 
6 0.465 0.343 -0.044 0.176 
7 0.163 0.419 -0.378 0.577 
8 0.382 0.602 -0.323 0.312 
1 -0.150 -0.073 -0.512 -0.088 
-0.398 0.231 0.003 0.003 -0.165 0.140 0.004 0.005 
2 -0.240 -0.008 0.125 0.194 
3 -0.180 -0.029 0.648 -0.547 
4 -0.398 0.107 0.169 -0.409 
5 -0.601 0.432 -0.198 0.231 
6 -0.373 0.144 -0.685 0.663 
7 -0.299 0.401 -0.457 0.583 
8 -0.944 0.876 -0.417 0.493 
1 0.695 -0.984 0.103 -0.697 
0.349 -0.442 0.002 0.004 -0.029 0.049 0.005 0.005 
2 0.423 -0.674 -0.173 0.204 
3 0.157 -0.361 0.634 -0.533 
4 0.189 -0.494 0.224 -0.451 
5 0.503 -0.709 -0.397 0.461 
6 0.176 -0.256 -0.357 0.316 
7 0.617 -0.527 0.131 0.569 







Figure S1.  HPLC chromatogram of the separation of Ovalbumin isoforms using operating conditions: Strong Anion-exchange column SOURCE 15Q 632 
4.6/100 PE, Flow Rate: 0.5 mL/min. Temperature: 25 °C .Inj. Volume: 100 μL Detection: UV, 280 nm. The peaks shown in Figure S1 and labelled as  633 
peaks 1, 2 and 3 were designated (P0G1), (P0G2) and (P0G3) respectively  under the assumption (deduced from the dephosphorylation experiment 634 
shown in Figure S2) that P0 is an isoform having zero phosphorylation and G1, G2 and G3 represent glycoforms differing in charge.  Peaks 4(P1G1) 635 
and 5(P1G2) represent ovalbumin with one site phosphorylated and similar glycan variants conveying additional negative charge, while peak 6(P2G1) 636 
and peak 7(P2G2) may represent ovalbumin having both phosphorylation sites modified but again with various glycan structures conveying additional 637 






























Figure S2.  HPLC-chromatogram to identify the phosphorylated sites in ovalbumin using the alkaline phosphatase strategy with treatment time of 1, 2, 640 
3 & 24 hours. The chromatogram of native ovalbumin as shown in Figure S1 indicated a variety of phosphate isoforms: peaks P0 represented 641 
dephosphorylated forms consisting of 3 different glycoforms (P0G1, P0G2, and P0G3). From which the remaining isoforms can be tentatively assigned 642 






















Ovalbumin treated with ALP for 1h
Ovalbumin treated with ALP for 2h





Figure S3. Separation of Bio-Rad standard during Size exclusion chromatography under the conditions: Buffer 0.05 M potassium phosphate ,0.3 M 646 
























Figure S4. SEC chromatogram for ALP treated and non-treated (native) ovalbumin, where retention was defined as Ve/V0; Ve is the elution volume of 654 
the analyte and V0 is the column void volume [S1].  No significant changes were seen such as proteolysis and the extent of aggregation (peak1) and 655 
presence of multimeric species (peak2) remained the same and the only change was found in the molecular size of protein (peak3), were under ALP 656 
treated SEC shows an apparent reduction in molecular weight corresponding to the de-phosphorylated state 657 
 658 
Reference: 659 
[S1] P. Hong, S. Koza and E.S. Bouvier, A review size exclusion chromatography for the analysis of protein biotherapeutics and their aggregates, J. 660 




















Treated Ovalbumin after 5H




Table S2. Molecular weight of the ovalbumin species as determined by SEC and shown in Fig S4 (above) 662 
Non-treated ovalbumin Treated ovalbumin 
Peak 
replicate 












1 346.30 105.0 43.7 346.3 104.0 40.5 
2 346.07 107.0 43.5 346.3 106.0 41.01 
3 346.37 108.0 43.5 346.3 102.0 41.3 
 663 
Table S3. Analysis of covariance (ANCOVA - IBM SPSS statistics version 20) was used to compare the two regression coefficients for the PEG3350 - 664 
Dextran500 system shown in Figure 8 in the associated paper. The method determines whether changes in the partition coefficient differ significantly 665 
with respect to the independent variable while considering the possible effects of the covariate. P values were found to be well below the 0.05 probability 666 
level. 667 
Tests of Between-Subjects Effects 
Dependant Variable: Cb 
Source Type III sum of squares df Mean square F Sig. 
Corrected Model 8.826a 2 4.413 137.568 0 
Intercept 0.041 1 0.041 1.265 0.281 
Ct 8.582 1 8.582 267.509 0 
Sample 0.407 1 0.407 12.680 0.003 
Error 0.417 13 0.032   
Total 33.411 16    
Corrected Total 9.243 15    
a. R squared =0.955 (Adjusted R squared =0.948) 668 
